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Abstract
The contribution of the animal environments to the worsening of the global 
antimicrobial resistance framework is related to the use of antimicrobials in 
subtherapeutic doses and, for long periods, establishing ideal conditions for the 
circulation of resistance genes, which can be transmitted to pathogens adapted 
to the human microbiota. The study of the animal environment as conducive 
to the acceleration of resistance evolution is an emerging and critical area for 
understanding the development and dissemination of resistance genes among the 
circulating bacteria. The connection between people, animals, and the environ-
ment allows us to consider antimicrobial resistance in an approach within the “One 
Health” concept, which provides a global strategy for expanding collaboration 
and interdisciplinary communication. This chapter will highlight the emergence 
of colistin resistance, a great challenge in antimicrobial resistance field. Also, it 
will focus on some agents included in the priority list of superbugs of the World 
Health Organization (WHO) or correlated species already identified in veterinary 
medicine, such as the critical superbugs; priority level 1, Carbapenem-resistant 
Acinetobacter baumannii, Carbapenem-resistant Pseudomonas aeruginosa, and ESBL-
producing Carbapenemic-resistant Enterobacteriaceae; and the high-priority, level 
2, methicillin-resistant Staphylococcus aureus (MRSA).
Keywords: one health, Staphylococcus pseudintermedius, Acinetobacter baumannii, 
mecA gene, mcr genes, beta-lactamases
1. Introduction
Global antimicrobial resistance indices are the subject of concern once it has 
been predicted that nearly 10 million annual deaths will be attributable to resistant 
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pathogen infections by 2050 [1, 2]. The World Health Organization (WHO), the 
US Center for Disease Control and Prevention (CDC), and the European Center for 
Disease Prevention and Control (ECDC) classified the emergence and the spread of 
antimicrobial-resistant bacteria as one of the three major threats to public health in 
the twenty first century [3].
Importantly, the emergence of resistance is a natural evolutionary response to 
antimicrobial exposure. Over thousands of years, fungi and bacteria in the natural 
environment have developed complex mechanisms to prevent their destruction by 
toxic substances originating from the microbial competition, and these substances 
have made it possible to synthesize most antibiotics. Therefore, soils should be 
evaluated as potential reservoirs of antimicrobial-resistant bacteria and should be 
considered in assessing risk factors that contribute to the global spread of antimi-
crobial resistance. Moreover, the active collaboration of the human being in the 
propitiation of this emergency is undeniable due to the increased selection pressure, 
mainly given by the indiscriminate use of these drugs in human and veterinary 
medicine [4].
Antimicrobials not only kill sensitive and select resistant bacteria but also influ-
ence the mechanisms of genetic variation such as mutation, recombination, trans-
position, and gene exchange. Such phenomena can be observed from the soil to the 
intestinal microbiota of humans or animals exposed to antimicrobial underdosing, 
as the population of commensal microorganisms includes species that are naturally 
resistant to some antimicrobials. This selective pressure and subsequent imbalance 
due to the death of sensitive microorganisms allow bacteria with intrinsic or newly 
acquired resistance to survive and proliferate [5].
Despite this general understanding, the multifactorial origin of the current 
worldwide antimicrobial resistance scenario makes the picture complex and chal-
lenging to intervene. Although studies point to the hospital environment as the 
main reservoir for the resistance genes of bacteria that colonize and infect humans, 
the community environment indeed contributes to the establishment of a diverse 
set of resistance genes [3].
In 2012, Bhullar and colleagues [6] found multiresistant bacteria from an 
isolated cave microbiome over 4 million years ago in New Mexico, and some of the 
microorganisms were resistant to up to 14 commercial antibiotics. In another study, 
the ability of bacteria to use antibiotics as their sole carbon source was detected, 
making them a significant reservoir of antimicrobial resistance genes [7].
In this context, little is known about the contribution of animal production 
and veterinary hospital care environments in the maintenance of resistance genes 
and consequent resistance dissemination. The study of the contribution of vari-
ous animal-related environments in accelerating the evolution of resistance is an 
emerging and critical area for understanding its development and as a model for the 
dissemination of resistance genes among the circulating bacteria. The connection 
between people, animals, and environment allows for the consideration of antimi-
crobial resistance within the One Health concept.
2.  Distinct animal environment and its impact on antimicrobial 
resistance
2.1  The poultry production environment as a source of emerging colistin 
resistance
The increase in antibiotic resistance is now a global concern, including in food-
producing animals. They can serve as a reservoir of antibiotic-resistant bacteria 
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and antibiotic resistance determinants that may be transferred to humans [8, 9]. 
The systematic use of antibiotics in food-producing animals has been increasing the 
selection pressure for antibiotic-resistant bacteria, especially in Enterobacteriales 
such as Escherichia coli [10]. Furthermore, the emergence of carbapenem-resistant 
bacteria worldwide and the increased use of polymyxins as “last-line” antibiotics to 
treat human infections may have contributed to the spread of its resistance [11, 12]. 
Due to its low price, colistin has been carried on for decades in the poultry industry, 
worsening this scenario. It is usually administered to the entire flock and mostly 
used for metaphylaxis and growth promotion in different countries [13].
2.1.1 The silent colistin transferable plasmid-mediated resistance dissemination
The chromosomal polymyxin resistance is most associated with the modification 
of the lipopolysaccharide (LPS) following the addition of 4-amino-4-deoxy-L-arab-
inose to lipid A. Modifications of Ara4N are regulated by two-component systems: 
PhoP/PhoQ , PmrA/PmrB, and MgrB regulator. Mutations in genes involved in the 
production of these systems may result in lower antibiotic fixation [14]. However, 
in 2015, a Chinese research group reported the emergence of a transferable plasmid-
mediated resistance gene (mcr-1) from human, porcine, and poultry samples, 
shifting colistin resistance from a contained problem to a global issue [15]. After 
identification of mcr-1, full scientific attention led to the recognition of multiple 
mcr-1 variants [16–18] and eight additional mcr genes. Subsequently, the mcr-2 
plasmid-mediated colistin resistance gene was detected from poultry, porcine, and 
bovine E. coli in Belgium [19]. A third mobile colistin resistance gene, mcr-3, has 
been reported in E. coli, Aeromonas spp., and Salmonella spp. isolates from human 
and animal samples in Asia and Europe [20]. The mcr-4 was detected in Salmonella 
enterica serovar Typhimurium and E. coli isolates from animal sources in Italy, 
Spain, and Belgium [21]. The mcr-5 was detected in poultry and poultry meat iso-
lates of S. enterica serovar Paratyphi from porcine E. coli in Germany [22]. The sixth 
mobile colistin resistance gene, mcr-6, was detected in Moraxella sp. from porcine 
in the United Kingdom [23]. The mcr-7 gene was detected in Klebsiella pneumoniae 
in China [9], the mcr-8 gene in K. pneumoniae from porcine and human in China 
[24], and finally, the mcr-9 gene from human in the United States of America [25]. 
Despite all these reports, a retrospective analysis demonstrated that the mcr-1 gene 
had been circulating since the 1980s with the earliest isolates from poultry [26]. 
So, the plasmid-mediated colistin resistance had been around for about 35 years 
without being detected until 2015. The silent colistin resistance dissemination could 
partly be explained by the fact that China is by far the leading colistin producer and, 
at the same time, the largest consumer of its production [15].
Nevertheless, colistin is often added to feed at low doses and used as a growth 
promoter in different countries. This practice may be the leading cause of the high 
rate of colistin-resistant bacteria carrying the mcr genes isolated from food-produc-
ing animals compared with humans and accelerate the dissemination of mcr genes 
from animals to humans [15, 27]. Furthermore, the mcr genes may have originated 
from food-producing animals. The mcr-1 gene was associated with ISApl1 insertion 
sequence element, which was first identified in the porcine pathogen Actinobacillus 
pleuropneumoniae [28], and finally, mcr-1-positive strains usually carry floR gene 
conferring resistance to florfenicol, a drug only used in veterinary medicine [10]. 
The mcr genes have also been found on diverse plasmid backbones (IncI2, IncHI2, 
IncX4, and pHNSHP45) with high in vitro transfer rates and often harbored 
together with other resistance determinants, such as β-lactamases [29]. The preva-
lence data on colistin resistance vary from different countries and continents. Data 
from two European AMR monitoring from 2014 to 2016 have reported low colistin 
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resistance rates for broilers and chicken meat in Nordic countries [29]. However, 
studies have shown moderate prevalence in turkey flocks, chicken and turkey meat 
in Germany [30] and Switzerland [31], and a high prevalence was found in Portugal 
[32]. In Asia, the prevalence of colistin resistance in poultry is higher than Europe. 
Different studies have been reported a remarkable increase in colistin resistance 
frequency in E. coli from porcine, poultry, and cattle in all geographic areas of 
China [33, 34].
2.1.2 Data on colistin resistance in Brazil
In 2015, Brazil overtook China as the world’s second largest poultry producer. 
Nowadays, about 150 countries from all continents consume Brazilian broiler 
meat, according to the Brazilian Ministry of Agriculture Livestock and Farming 
[35]. It is noticeable that scientific and technological advancements have trans-
formed poultry from rural farming to full-fledged industry in the last few decades. 
However, despite this significant expansion, the Brazilian poultry industry is still 
highly dependent on antibiotic prescription. Prevalence data on colistin resistance 
in poultry and broiler are overall scarce in South America, including Brazil, in 
particular, data regarding the plasmid-mediated resistance to colistin [36–38]. In 
2016, a Brazilian research group developed a retrospective antimicrobial resistance 
study and screened 4.620 Enterobacteriales strains isolated from human, animal, 
food, and environmental samples for the presence of the mcr-1 gene. Samples were 
collected from 2000 to 2016. In this study, mcr-1 gene was detected in 16 E. coli 
strains from poultry and porcine isolated between 2012 and 2013. This surveillance 
showed evidence that mcr-1-harboring E. coli has been circulating in food-produc-
ing animals in Brazil since 2012 [36]. In 2017, the same research group detected the 
presence of mcr-1-harboring E. coli strains isolated from commercial chicken meat 
sold in markets in São Paulo, southeastern Brazil. Most E. coli strains exhibited an 
MDR phenotype and carried IncX4 plasmids, previously identified in human and 
animal isolates [38].
Furthermore, between 2015 and 2016, Pimenta [39] also detected a high 
prevalence of mcr-1-harboring E. coli from broilers and free-range layer hens in 
several poultry farms in Rio de Janeiro, southeastern Brazil. Most E. coli strains 
carried IncI2, FIB, and B/O plasmids. In November 2016, the MAPA banned the 
use of colistin as a feed additive for animal growth promotion purposes (regulatory 
instruction no. 45 [http://www.agricultura.gov.br/]), following the international 
recommendations of the World Health Organization. Despite this government 
action, in 2019, our group detected a high prevalence of the mcr-1 gene as the only 
resistance gene in E. coli strains isolated from broilers in several poultry farms in 
Rio de Janeiro (unpublished data). Data suggest that poultry is still an important 
reservoir to colistin resistance gene mcr-1. As poultry meat is an inexpensive source 
of protein, its impact on transferring resistance cannot be neglected. The overuse 
of antibiotics will promote the unrestricted expansion and circulation of drug-
resistant strains among the human-animal environment. Therefore, continuous 
surveillance must be of great concern, improving prevalence data in both human 
and veterinary settings.
2.1.3 Colistin resistance genes in soils
Colistin, also known as polymyxin E, is produced by some strains of 
Paenibacillus polymyxa, a bacterium commonly found in soils associated with plant 
roots [40]. In some places around the world, the use of poultry litter is an ordinary 
measure to improve the physical, chemical, and biological properties of soils in 
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agricultural production. However, animal manure, such as poultry litter, a mixture 
of organic materials including feces, feed, and bedding, is a valuable nutrient-
rich soil fertilizer also has been considered an important reservoir of antibiotic 
residues, antibiotic-resistant bacteria, and antibiotic resistance genes [41, 42]. The 
enhancement of the concentration and diversity of antibiotic resistance determi-
nants in soils treated with this organic fertilizer is of concern, even considering 
that untreated soil environments harbor a natural source of both antibiotics and 
antibiotic resistance genes [43–46]. The colistin resistance mcr-1 gene was detected 
in all soil samples from intensive vegetable production that received poultry litter as 
organic fertilizer but also in native vegetation areas that comprise a legal reserve at 
a mountain region of Rio de Janeiro, Brazil, confirming the previous statement that 
even natural soil environments act as a reservoir of resistance determinant [47].
2.2  Animal production environmental impact on genetic markers mutations: a 
study of mecA gene of Staphylococcus aureus isolated from dairy system
Methicillin-resistant Staphylococcus (MRS) spp. are important human pathogens 
that are also a concern in veterinary medicine and animal agriculture. Staphylococcus 
species are present in a wide range of animal species, including dogs, cats, rabbits, 
horses, cattle, pigs, poultry, and exotic species, both in healthy carriers and as a 
cause of infection [48–50]. Besides the broad host range distribution and pathoge-
nicity, its significant antimicrobial resistance levels are of great concern [51]. The 
high antimicrobial resistance level to beta-lactams favors treatment failures and its 
persistence in the environment. Bacterial resistance mechanisms to this antimicro-
bial class include a low-affinity penicillin-binding protein 2a (PBP2a) determined 
by the expression of the mecA gene [52]. The phenotypic methicillin-resistant 
expression does not depend only on the mecA gene. This expression is under a more 
complex control and is only beginning to be better understood since it is expressed 
in a peculiar and heterogeneous way [53]. Because of this phenotypic heterogeneity, 
detection of the mecA gene is considered the gold standard method for the confir-
mation of methicillin-resistant isolates by the Clinical Laboratory Institute [54, 55]. 
However, for samples of animal origin, this proposition is not reliable, since vari-
ants of the mec gene impair this detection [56, 50].
2.2.1 The mecC homolog
In 2011, the report of MRSA strains presenting unusual features in bovine milk 
samples from the United Kingdom led to the discovery of a novel mecA gene named 
mecALGA251 [57]. This gene presented just 70% similarity at the nucleotide level to 
the classical mecA gene and could not be detected by routine PCR assays targeting 
the latter [57]. Shortly after its description, the mecALGA251 was isolated from 
human clinical infections in the United Kingdom, Denmark, and Ireland [58]. It 
was renamed as mecC gene and has been reported from 13 European countries and 
have been isolated from 14 different host species [59]. Recently, Loncaric et al. [60] 
reported its occurrence in coagulase-negative staphylococci (CoNS) from various 
wild and domestic animals. The discovery of the mecC gene reinforced the idea 
of the circulation of gene variants in the animal production environment and the 
consequent emergence of new methicillin-resistant strains [61]. Until now, the 
detection of the mecC gene is a challenge, and even though there are several reports 
of the mecC gene in Staphylococcus species from humans and animals, the puzzling 
question is that they are all restricted to European countries. In Brazil, the presence 
of mecALGA251 in the bovine isolates tested negative for mecA was investigated, but 
all isolates also tested negative for the mecALGA251 [50].
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2.2.2 A universal primer design experiment
Previous studies [62, 63] reported several phenotypic methicillin-resistant 
Staphylococcus spp. isolates not correlated with the presence of the mecA gene. 
Otherwise, Melo et al. [56] reported the discovery of a mecA gene variant from 
bovine samples containing mutations in the annealing region that does not allow 
detection of the gene with the already described primers. It was detected that 
the primer F’s annealing site based on the human S. aureus mecA gene specified 
by Murakami et al. [64] presented punctual nucleotide differences that possibly 
impaired the annealing and amplification of mecA gene from the bovine strains. 
A two-set study was conducted to confirm this hypothesis. Firstly, original prim-
ers were synthesized based on the nucleotide sequences of the mecA gene of 
Staphylococcus aureus (HE681097). Those primers failed in amplifying the whole 
mecA gene segment in bovine strains. Instead, they did it successfully for human 
and equine Staphylococcus strains. Next, a second-step primer set was based on a 
sequence of S. sciuri mecA gene (AY820253) and only yielded mecA gene segments 
for bovine strains. The multiple alignments of mecA gene sequences from bovine, 
human, and equine origins revealed that bovine ones presented punctual but 
significant differences leading to the observed impairment of mecA gene detection 
in bovine strains. This divergence of mecA gene sequences is a specificity of bovine 
samples, probably due to some selective pressure in the dairy environment [56].
To validate the newly designed primers, a set of 107 strains was tested for the 
presence of the mecA gene and its bovine variant in Staphylococcus spp. isolates 
from dairy farms in Brazil and Turkey. Seventeen isolates tested positive for the 
mecA variant, nine from Turkey, and eight from Brazil [65]. Recently, a universal 
PCR primer set was developed and validated to ensure adequate detection of the 
mec genes (classical and variant) [50]. A set of 563 Staphylococcus spp. of different 
animal origins, from the United States of America, and 248 isolates from Brazil, was 
tested, and 220 (39.1%) were confirmed as MRS by amplification using a classical, 
variant, and universal primers. The classical mecA gene was detected in 201 isolates, 
being 177 S. aureus, whereas the variant mecA was detected in 14 isolates, being 
2 S. aureus and 12 CoNS isolates. These results reinforce that the variant mecA is 
widespread in the animal environment. Surprisingly, a single strain of S. xylosus 
isolated from a porcine nasal swab carried both mec genes (classical and vari-
ant). The developed universal primer set successfully amplified mec genes in 205 
isolates, even four isolates that did not amplify any classical or variant mecA using 
conventional primers. It presented sensitivity, specificity, positive predictive, and 
negative predictive values higher than 90%, comparing to the classical mec gene 
detection. Also, it presented a higher discriminatory power once four isolates just 
amplified mec genes using this primer set. This report is of high relevance once the 
development of tools to improve MRS diagnosis is crucial for its accurate and rapid 
identification. The dairy environment represents a considerable challenge in the 
emergence of new variants of beta-lactam resistance genes due to the frequent use 
of this antimicrobials class to prevent subclinical mastitis.
2.3 Companion animals environmental impact on antimicrobial resistance
Companion animals are part of human societies around the world [65]. In 
veterinary medicine clinical practice, diseases such as pyodermitis, external otitis, 
urinary tract, and respiratory infections are the most frequent causes for the imple-
mentation of antibiotic therapy in dogs and cats. Wide-spectrum antimicrobials 
also prescribed in human medicine are commonly used in these treatments, such as 
aminopenicillins with beta-lactamase inhibitors, cephalosporins, fluoroquinolones, 
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macrolides, aminoglycosides, and potentiated sulfonamides [66]. As a result, the 
extensive and indiscriminate use of such antimicrobials in companion animals, 
coupled with their proximity to humans, gives canine and feline species impor-
tance as sources of antimicrobial resistance spread [67]. In the last decade, the 
escalation of infectious conditions in the veterinary clinic of pet animals related 
to hitherto unknown or low prevalence agents such as Acinetobacter calcoaceticus-
Acinetobacter baumannii complex (Acb complex). Parallel to this, the advances in 
molecular biology applied to bacteriological diagnosis allowed the reclassification 
of pathogens, and to identify the sharing pathways to virulence and resistance genes 
between closely related species, as occurs with Staphylococcus pseudintermedius, 
a species reclassified from molecular studies, with some significant gene sharing 
with Staphylococcus aureus, the most recognized species of this genus, of significant 
importance in human medicine.
2.3.1  Acinetobacter calcoaceticus-Acinetobacter baumannii complex (Acb 
complex): an emerging challenge in companion animal environment
The Acinetobacter calcoaceticus-Acinetobacter baumannii complex (Acb complex) 
is formed by highly genetically related Gram-negative bacteria, which makes 
species identification difficult through routine laboratory phenotypic methods 
[68]. The Acb complex comprises Acinetobacter baumannii and its close relatives, A. 
calcoaceticus, A. dijkshoorniae, A. lactucae, A. nosocomialis, A. pittii, and A. seifertii 
[69]. The clinically relevant species include A. baumannii, A. pittii, and A. noso-
comialis [70]. Members of this complex have emerged as opportunistic pathogens 
causing infections in human and animal health facilities [71]. Infections include 
pneumonia, especially in ventilated patients; urinary tract infections, especially 
in patients with urinary catheters; and other infections associated with the use of 
intravascular catheters [72]. Infections caused by Acb complex agents are dif-
ficult to treat since these pathogens have intrinsic resistance to different classes of 
antimicrobials and also have the ability to acquire additional resistance genes [73]. 
Infections caused by representatives of the Acb complex has become a growing 
challenge in clinical routine, both human and animal, especially considering the 
multiresistant character of these pathogens. Further, there are currently few studies 
in the field of veterinary medicine that report the occurrence of the other species of 
this complex, besides A. baumannii, as well as the resistance profile.
The analyses developed by our research group have identified all three species 
of clinical relevance of Acb complex, with the prevalence of A. pittii, in samples of 
animal infectious processes, which has also presented multiresistant profiles. The 
identified multidrug-resistant isolates were mainly involved in urinary tract infec-
tions of dogs and cats, which confirm the real challenge in the veterinary clinical 
routine. These findings reinforce the need for proper investigation of these agents 
in the veterinary environment for the adoption of appropriate control and treat-
ment measures. Carbapenemic antimicrobials constitute an excellent alternative for 
the treatment of infections caused by these pathogens. However, carbapenemases 
production is one of the biggest challenges in the healthcare system [74]. Agents of 
Acb complex have become resistant to carbapenems through different mechanisms, 
including the presence of metallo-beta-lactamases (class B) and the presence or 
overexpression of OXA (class D) carbapenemases, especially blaOXA-23, blaOXA-24, 
blaOXA-58, and blaOXA-51. Considering the species A. baumannii, the gene blaOXA-51 
codes for the intrinsic carbapenemase [73]. This additional resistance conferred by 
OXA-type carbapenemases is commonly grouped into resistance islands located in 
a region that favors insertion or deletion within the bacterial chromosome [75]. The 
ISAba1 insertion sequence located in the upstream region of the OXA genes, such as 
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blaOXA-23, results in increased expression of this gene, observed by an increase in the 
minimal inhibitory concentration for carbapenems [76]. In addition to antimicro-
bial resistance, another factor that has favored the emergence of infections caused 
by species of the Acb complex is related to the biofilm formation capacity of these 
pathogens, which contributes to their survival in environmental conditions, favor-
ing their persistence in hospital devices, and on different abiotic and biotic surfaces 
[77]. Biofilm-associated infections require higher doses of antibiotics, resulting in 
antimicrobial resistance, increased death, prolonged hospital stays, considerable 
economic loss, and loss of protection for patients [78].
2.3.2  Staphylococcus pseudintermedius: an underestimated risk for animal  
and men
Staphylococcus pseudintermedius was first described as S. intermedius [79] 
based on bacterial isolates from pigeons, dogs, minks, and horses. For decades, S. 
intermedius was considered the leading species of staphylococci associated with 
skin and soft tissue infections in dogs until it was demonstrated that S. intermedius 
was actually a heterogeneous group of bacteria [80]. Devriese et al. [80] described 
the S. pseudintermedius species through DNA hybridization and 16S rRNA gene 
sequencing. Subsequent studies evaluated the phenotypic and genotypic diversity 
in S. intermedius and differentiated it into four distinct species: S. intermedius, S. 
pseudintermedius, S. delphini, and S. cornubiensis which are together referred to as 
the Staphylococcus intermedius group (SIG) [81–83]. Since then, S. pseudinterme-
dius has been recognized as the common cause of skin infections in dogs, and it 
has been proposed that all canine isolates should be termed S. pseudintermedius 
unless genotypic typing methods reveal otherwise [84]. This coagulase-positive 
staphylococci (CoPS) is commensal to the skin and mucosa of healthy dogs, 
including hair follicles, conjunctival sacs, nares, oral cavity, and perianal region 
[85]. It is an opportunistic pathogen, capable of causing disease when the natural 
resistance of the host is suppressed or when the skin barrier is changed [81]. 
Atopic dermatitis, medical or surgical procedures, and immunosuppressive 
diseases are examples of predisposing factors to infection [81]. This pathogen is 
the leading cause of skin and ear infections but may also cause infection in other 
tissues and cavities and may be transmitted in the community or hospital setting 
[48, 81, 85]. Besides being the leading cause of canine pyoderma, S. pseudinter-
medius is also frequently isolated from samples of urinary tract infections and 
may be a complicating factor in immunomodulatory-responsive lymphocytic-
plasmacytic pododermatitis [81].
Although dogs are the natural hosts, S. pseudintermedius can colonize and infect 
other animal species, mainly cats [86, 87]. Staphylococcus pseudintermedius and 
S. aureus are the species of CoPS that may be composed of the commensal skin 
microbiota in cats, but there is no consensus in the veterinary literature as to which 
is dominant and geographic factors should be considered [88]. In these animals, S. 
pseudintermedius can cause tissue infections, rhinitis, nephritis, pneumonia, urinary 
tract infections, and septicemia [87, 89, 90]. Since the first report of human infec-
tion by S. pseudintermedius [86], infections have been reported occasionally and are 
often directly related to close contact with a dog [81]. Pet owners with S. pseudinter-
medius infections and veterinarians are more likely to be nasally colonized by this 
agent than other individuals [91–93]. S. pseudintermedius infections associated with 
dog bite wounds and post-mastoidectomy, onycholysis, otitis externa, sinusitis, 
bacteremia, hospital acquired pneumonia, and brain abscess procedures have been 
described in humans [94–102].
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2.3.2.1  Is methicillin-resistant Staphylococcus pseudintermedius (MRSP) the 
novel MRSA?
Two cases of methicillin-resistant S. pseudintermedius (MRSP) infection have 
been described in patients with sinusitis, and in one case, at first, S. pseudinter-
medius was misidentified as MRSA [102, 103], suggesting that there may be an 
underreporting of cases due to the misidentification of the agent. Twenty-four cases 
of human infections caused by S. pseudintermedius were reported in Canada, most 
of them associated with skin and soft tissue infections, and in three of them, the 
strain involved was multidrug-resistant [104]. Human MRSP infections in patients 
without any contact with dogs suggest that humans may eventually be colonized 
by MRSP [104, 105] and that human-to-human transmission may occur [81]. These 
reports highlight the importance of S. pseudintermedius as a potential emerging 
pathogen of zoonotic origin and the need for further studies to understand the 
transmission to humans and to recognize this epidemiological phenomenon.
The relevance of S. pseudintermedius as a pathogen is also related to its antimicro-
bial resistance potential [48]. The inappropriate prescription and use of the same 
drugs in humans and animals provide a selection of multidrug-resistant (MDR) 
isolates and consequently compromise the treatment efficacy [106]. Beta-lactam 
antibiotics are often the first choice of treatment for Staphylococcus-associated 
infections [107], and methicillin-resistant staphylococci (MRS) are an increasing 
concern. The emergence of MRSP worldwide has become a major problem for small 
animal veterinary medicine [108] and the infections caused by this agent, a chal-
lenge. This resistance is mainly due to two distinct mechanisms: the production of 
the beta-lactamase enzyme, encoded by the blaZ gene, and the production of the 
additional low-affinity penicillin-binding protein (PBP2a), which is encoded by 
the mecA gene and regulated by mecI and mecRI genes. PBP2a determines oxacillin/
methicillin resistance due to its reduced affinity for beta-lactams and can carry out 
transpeptidation reactions when normal PBPs are blocked by the drug, allowing 
peptidoglycan synthesis and conferring resistance to all antimicrobials of the beta-
lactam class [109].
The mecA gene is located in a mobile genetic element called staphylococcal cas-
sette chromosome (SCCmec) chromosomal cassette, which can be transferred via 
plasmid, transposons, or mobile genetic elements and integrate into the bacterial 
genome [110, 111]. The mec cassette is made up of two main components: the mec 
complex, composed of the IS43 pathogenicity island, the mecA gene, and its mecI 
and mecRI regulators, and by the ccr complex that encodes the chromosome cas-
sette recombinases, which are responsible for the correct excision and consequent 
integration of this element into the staphylococcal chromosome [112].
The mec cassette may carry other genetic elements such as Tn554, pUB110, and 
pT181, which encode resistance to other classes of antimicrobials. For example, the 
erm genes, which are responsible for constitutively expressed or induced cross-
resistance to macrolides, lincosamides, and streptogramin B (MLSB), are located 
in Tn554, present in SCCmec types II and III [113, 114]. Horizontal transfer of the 
mecA gene into staphylococci and the genetic elements inserted into the SCCmec 
thus resulted in the worldwide spread of oxacillin/methicillin and MDR clones, 
making it an additional difficulty to control infections caused by these agents [113]. 
MDR is often observed in MRSP strains [115–117], which also constitute a reservoir 
of resistance genes for other staphylococci [108] and represents a major problem as 
the distribution and prevalence of these organisms in animal clinical specimens are 
relatively unknown, as well as the presence and circulation of genes such as mecA 
and its potential for propagation in companion animals.
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2.3.2.2  Staphylococcus pseudintermedius: genetic diversity and clonal 
distribution
In addition to the challenges of identifying S. pseudintermedius, there is a need 
for standardized typing methods that support an epidemiological investigation 
and monitoring of MRSP [81]. Different techniques have been employed to char-
acterize and determine the genetic diversity among MRSP strains. Pulsed field gel 
electrophoresis (PFGE), spa gene typing, multilocus sequence typing (MLST), 
and SCCmec cassette typing are commonly used. Despite a considerable number of 
studies seek to understand the population dynamics of S. pseudintermedius world-
wide, little is known about the clonal distribution patterns of MRSP strains from 
Africa and South America [118].
In Brazil, the prevalence of methicillin-resistant Staphylococcus pseudintermedius 
(MRSP) as a cause of infectious diseases in companion animals remains unknown. 
A recent study, developed by Motta [119] provides an overview of the prevalence 
and characterization of multidrug-resistant MRSP strains from canine and feline 
clinical samples in Rio de Janeiro. A significative occurrence of multidrug resistance 
(MDR) in MRSP strains from Brazilian canine and feline clinical was revealed: 
all MRSP strains analyzed were resistant to seven different antimicrobial classes: 
fluoroquinolones, phenicols, macrolides, aminoglycosides, aminoglycosides, 
lincosamides, and tetracyclines. Among these strains, four closely related spa types 
were detected, with predominance of t02. Two clones were identified by the PFGE 
technique and four closely related strains (groups III and X). MLST typing revealed 
the presence of three STs/CCs (ST/CC71, ST265/CC258 and ST282/CC45) never 
reported previously in MRSP strains derived from canine and feline clinical samples 
from Brazil, with predominance of the worldwide disseminated ST/CC71-spat02-
SCCmecII-III strain. Comparative analysis of the typing methods used revealed the 
importance of combining techniques for a broader understanding of the genetic 
diversity of MRSP. The report highlights the need for further studies to determine 
the prevalence and characteristics of MRSP from Brazil, supporting preventive and 
control measures to overcome the antimicrobial resistance.
2.4 β-Lactamase-producing Gram-negative bacteria in a one health approach
Most Enterobacteria pathogens associated with human enteric illness originate 
from animals and can be transmitted directly to humans or indirectly through 
animal origin food, contaminated water, or a common reservoir [120]. Currently, 
β-lactamase-producing strains have been recovered from urban environments, 
companion/production animals, and animal source foods, which indicate a possible 
route of dissemination in different ecosystems.
To better understand these links and to identify control measures to reduce 
the bacterial resistant infections in humans and animals, a One Health approach 
is needed [121, 122]. The application of a global concept of cross-linking data will 
improve the prevention, prediction, and control of zoonotic diseases [123, 124].
Undoubtedly, the mobilization of resistance genes through plasmids, transpo-
sons, and integrons is intimately linked with widespread of β-lactamases, facilitat-
ing the exchange of genetic elements among various bacteria species that can later 
colonize different hosts and ecosystems and can be spread by different routes [125].
The detection of ESBLs in bacterial isolates of animal origin, such as 
Acinetobacter baumannii, has raised concern regarding the transmission of ESBL 
genes between human and animal [126]. Also, E. coli strains carrying AmpC-
β-lactamases have already been reported in healthy and sick animals and food-
producing animals [127, 128]. AmpC-hyperproducing E. coli was detected in dairy 
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herds in Brazil in 2019. Since there was no previous report of these AMR bacteria 
in dairy cattle, it was not possible to compare the mutation positions. Nevertheless, 
many of the positions observed in E. coli from beef cattle, broiler, and meat had 
already been described for human samples. These findings demonstrate a pos-
sible transmission route for these bacteria in the food chain and its dissemination 
through the environment [129].
ESBL or plasmidial AmpC-β-lactamase producers are also frequently resistant 
to aminoglycosides and fluoroquinolones. The rate of resistance to these antibiot-
ics among E. coli isolates of animal origin has been increasingly reported, and the 
impact of animal-derived broad-spectrum-β-lactamase-producing Gram-negative 
bacteria on public health has drawing considerable attention worldwide [127].
2.4.1 β-Lactamases resistance in Gram-negative bacteria
The most common mechanism of resistance to beta-lactam antibiotics in 
Gram-negative bacteria is the production of hydrolytic enzymes of antimicrobial 
agents, including extended-spectrum beta-lactamases (ESBLs) [130]. Two sys-
tems of classifying this array of enzymes are in use: the Bush-Jacoby-Medeiros 
activity-based system [131] and the Ambler system [132] based on nucleotide and 
amino acid sequence information [133]. The resistance to beta-lactamase inhibitors 
characterizes the group I (Ambler class C) beta-lactamases (also known as AmpC 
enzymes). AmpC is mostly found on chromosomes, and its production is induc-
ible. Group 2 (Ambler Class A) beta-lactamases could easily be transmitted into 
different bacterial cells once plasmids carry them. This group comprises the largest 
number of characterized enzymes divided into subgroup 2b hydrolyzing penicillins 
and cephalosporins and its variation 2be (known as “ESBL”). ESBL present a broad 
spectrum of various antimicrobials as ceftazidime, cefotaxime, and aztreonam. 
Clavulanic acid exerts potent inhibition towards them. Group 3 (Ambler Class B) 
enzymes are metalloenzymes capable of destroying carbapenems. Finally, group 4 
beta-lactamases contain those unusual penicillinases not inhibited by clavulanic 
acid, and four of these enzymes exhibit high rates of hydrolysis with carbenicillin or 
cloxacillin [134].
The spread of extended-spectrum β-lactamase-producing Gram-negative bac-
teria has dramatically increased worldwide regarding as one of the most important 
public health threats. Therefore, their appropriate classification and epidemiologi-
cal data on the main enzymes disseminated in humans, animals, and the environ-
ment are of utmost importance.
2.4.2 An historical approach
The first plasmid-mediated beta-lactamase in Gram-negative bacteria was 
reported in Greece in the 1960s. At the end of the 1970s, most Escherichia coli 
(E. coli) and Klebsiella pneumoniae (K. pneumoniae) strains contained ampicillin 
hydrolyzing β-lactamases mediated by plasmid (TEM-1, TEM-2, and SHV-1). They 
could be eliminated using third-generation cephalosporins [135]. The emergence 
of K. pneumoniae strains to harbor a gene encoding β-lactamase that hydrolyzes the 
extended-spectrum cephalosporins was firstly reported by a study from Germany 
in 1983. Further, in 1986, K. pneumoniae strains resistant to the third-generation 
cephalosporins were detected in France [136, 137]. This resistance was attributed 
to a new β-lactamase gene, closely related to TEM-1 and TEM-2, and these newly 
detected enzymes capable of hydrolyzing extended-spectrum beta-lactam antibiot-
ics were named extended-spectrum β-lactamases (ESBLs) [138]. In 1989, a new 
ESBL family member not belonging to either the TEM or SHV types was reported: 
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CTX-M type. Its origin has been confirmed to be completely different from that 
of TEM or SHV ESBL [139]. Nowadays, more than 600 ESBL has been described, 
the majority belonging to the CTX-M families and TEM-1/2, SHV-1 β-lactamases 
mutants [140].
2.4.3 The CTX-M-type β-lactamase resistance dissemination
The CTX-M-type β-lactamases can be further differentiated into at least six 
sub-lineages or groups, namely, CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, CTX-
M-25, and KLUC [141]. The impressive worldwide spread of CTX-M-producing 
Gram-negative bacteria turned them to be considered the primary ESBL producers 
associated with community-acquired infections. The CTX-M family is described 
as predominant in South America, as well as in Spain and Eastern Europe [142]. 
Therefore, according to the increasing number of reports describing these enzymes 
in Brazil, it appears that CTX-M variants are also prevalent in the country compared 
to TEM and SHV enzymes, prevalent in North America and Western Europe, 
respectively [143]. In Brazil, CTX-M has been reported in several states; CTX-M-2, 
CTX-M-8, and CTX-M-9 subtypes are the most prevalent in human samples. In 
animal production species such as poultry, swine, cattle, and horses, the prevalent 
enzymes are CTX-M-2, CTX-M-8, and CTX-M-15 [144]. Unfortunately, there are 
no nationwide surveillance programs on bacterial resistance and its mechanisms, 
making it difficult to estimate the proportion of ESBL producers [141].
2.4.4 The AmpC-type β-lactamases
Another enzyme group of the β-lactamases type is AmpC. They are relevant 
enzymes produced constitutively or induced by chromosomal or plasmidial genes 
expressed by members of Enterobacterales and other Gram-negative bacteria. This 
class of β-lactamases belongs to the functional groups 1 and C of the Bush and 
Ambler’s classification, respectively [129]. They are often overlooked because they 
are not within groups 2b or 2b, as CTX-M, TEM, and SHV. AmpC producers hydro-
lyze almost all β-lactam antibiotics, including cephalosporins, cephamycins, and 
penicillins, solely or associated with Β -lactamase inhibitors, limiting therapeutic 
options to treat infections caused by these resistant bacteria.
Of major concern is the hyperproduction of this enzyme in E. coli. This phenom-
enon is caused by spontaneous mutations that produce deregulation of ampC and 
is responsible for resistance to first-, second-, and third-generation cephalosporins 
and to extended-spectrum beta-lactamase inhibitors [145]. Also, some mutations 
can induce the appearance of an extended-spectrum AmpC (ESAC) that can hydro-
lyze fourth-generation cephalosporins and carbapenems. Once carbapenems are the 
choice therapy for Enterobacteria-producing extended-spectrum beta-lactamase 
infections, the detection of ampC production and its control represent an even big 
challenge.
2.4.5 The carbapenemases
The carbapenem resistance is related to the production of β-lactamases with 
versatile hydrolytic capacities. Currently, the most important type of class A 
carbapenemases are KPC enzymes, whereas VIM, IMP, and (particularly) NDM 
in class B and OXA-48 (and related) in class D are the more relevant enzymes. 
Most carbapenemases are plasmid-mediated (with genes frequently located in 
integrons), favoring its dissemination [146]. Since carbapenemase-producing 
Gram-negative bacteria generally also contain gene coding for other beta-lactam 
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resistance mechanisms, it is not uncommon for organisms to exhibit complex 
beta-lactam resistance phenotypes. Besides, these organisms often contain other 
genes that confer resistance to quinolones, aminoglycosides, tetracyclines, sulfon-
amides, and other families of antimicrobial agents that cause multidrug resistance 
(AMR) or even pan-resistance. The emergence of new variants and the prevalence 
of β-lactamases in isolates of community, environmental, and animal origin has 
demonstrated the complexity of establishing the origin of resistance.
2.4.6 Challenges in detecting the prevalence of β-lactamases
The incidence of large-scale beta-lactamase-producing organisms’ spectrum is 
difficult to determine. There are significant differences between the detection and 
interpretation methods used by countries and health institutions throughout the 
study [147]. Considerable phenotypic confirmatory tests for ESBL (2be and 2b) 
producers have been described in the literature, and all methods utilize the charac-
teristics of ESBL production inhibition by clavulanic acid.
The Clinical and Laboratory Standard Institute (CLSI) recommended test 
consists of an initial screening by disk diffusion or by the broth dilution method 
with ceftazidime, ceftriaxone, cefotaxime, cefpodoxime, and aztreonam followed 
by a phenotypic confirmatory test with cefotaxime and ceftazidime in the presence 
and absence of clavulanate [54]. The European Antimicrobial Susceptibility Testing 
Committee (EUCAST) [148] also recommends these tests, but both documents pre-
conize different disk concentrations, and there are also differences in susceptibility 
zone sizes for consideration of resistance patterns. These factors lead to difficult 
interlaboratory standardization and consequently to the correct definition of local, 
regional, and national epidemiological data.
Specifically, regarding AmpC, the Clinical and Laboratory Standards Institute 
(CLSI) offers no standard test to detect AmpC producer isolates. There are few 
antimicrobial agents safely effective against these isolates, and many of them are 
not available or even not approved for animal use. Although different detection 
methods are available, the lack of international standardization limits the reporting 
of AmpC by clinical laboratories, which may underestimate this important mecha-
nism of antimicrobial resistance [149].
3. Conclusions
Different environments related to animal production and clinical care can act as 
a source of the emergence of resistance genes. Studies developed over two decades 
show that there are relevant peculiarities that must be considered in the detection 
and understanding of emerging resistance in animal environments to achieve a 
systemic and practical approach to control antimicrobial resistance worldwide. 
This chapter discussed some current challenges, the importance of the poultry 
production environment in the significant emergence of colistin resistance, the 
development of a universal primer that made it possible to detect a variant of the 
mecA gene in Staphylococcus aureus from the dairy environment, and the emergence 
of Acinetobacter baumannii-Acinetobacter calcoaceticus complex and methicillin-
resistant Staphylococcus pseudintermedius considering companion animals. Finally, 
the significant dissemination of the resistance mechanism is determined by the 
production of different classes of beta-lactamases in Gram-negative bacteria in 
human and animals environments. These concepts allow considering antimicrobial 
resistance in a One Health approach, which provides a global strategy for expanding 
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